rs11396059
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001037732.3(DEFB128):c.183dupA(p.His62fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 1,613,820 control chromosomes in the GnomAD database, including 763 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.030 ( 67 hom., cov: 31)
Exomes 𝑓: 0.029 ( 696 hom. )
Consequence
DEFB128
NM_001037732.3 frameshift
NM_001037732.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.932
Genes affected
DEFB128 (HGNC:18106): (defensin beta 128) Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 20-187984-G-GT is Benign according to our data. Variant chr20-187984-G-GT is described in ClinVar as [Likely_benign]. Clinvar id is 3057209.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0303 (4612/152192) while in subpopulation AFR AF= 0.0388 (1610/41528). AF 95% confidence interval is 0.0372. There are 67 homozygotes in gnomad4. There are 2308 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 67 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB128 | NM_001037732.3 | c.183dupA | p.His62fs | frameshift_variant | 2/2 | ENST00000334391.5 | NP_001032821.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB128 | ENST00000334391.5 | c.183dupA | p.His62fs | frameshift_variant | 2/2 | 1 | NM_001037732.3 | ENSP00000335382.4 |
Frequencies
GnomAD3 genomes AF: 0.0303 AC: 4612AN: 152074Hom.: 68 Cov.: 31
GnomAD3 genomes
AF:
AC:
4612
AN:
152074
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0265 AC: 6648AN: 251146Hom.: 129 AF XY: 0.0268 AC XY: 3644AN XY: 135724
GnomAD3 exomes
AF:
AC:
6648
AN:
251146
Hom.:
AF XY:
AC XY:
3644
AN XY:
135724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0285 AC: 41670AN: 1461628Hom.: 696 Cov.: 33 AF XY: 0.0283 AC XY: 20572AN XY: 727128
GnomAD4 exome
AF:
AC:
41670
AN:
1461628
Hom.:
Cov.:
33
AF XY:
AC XY:
20572
AN XY:
727128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0303 AC: 4612AN: 152192Hom.: 67 Cov.: 31 AF XY: 0.0310 AC XY: 2308AN XY: 74414
GnomAD4 genome
AF:
AC:
4612
AN:
152192
Hom.:
Cov.:
31
AF XY:
AC XY:
2308
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
DEFB128-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 01, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at